Rapport Share Price

Rapport Share Price

NASDAQ: RAPP | Small Cap | Healthcare
$23.62
+$0.21 (0.90%) Last updated on 20 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Rapport Stock Performance

Open
$23.49
Prev. Close
$23.41
Circuit Range
N/A
Day Range
$23.49 - $23.98
Year Range
$22.08 - $52.93
Volume
10,492
Average Traded
$23.66

Rapport Share Price Today

As of 20 November 2026, Rapport Therapeutics, Inc.'s share price is $23.62. The stock opened at $23.49, compared to its previous close of $23.41. During today's trading session, Rapport Therapeutics, Inc.'s share price traded between $23.49 and $23.98, with an average price of $23.73. Over the past 52 weeks, the stock has recorded a high of $52.93 and a low of $22.08. In terms of performance, Rapport Therapeutics, Inc.'s share price has declined by 40.19% over the last six months and is down 20.26% on a year-on-year basis.

Rapport Share Price Chart

Line chart of the Rapport price trend over the selected period. The price rose overall, ranging from 22.92 to 24.13, ending at 23.43.
$23.49$23.98
L
Show Current Price
H

Rapport Stock Fundamentals & Key Indicators

Market Cap
$919.63M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.54
Revenue (TTM)
$0.00
Return On Equity (TTM)
-38.46%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-19.19%

Rapport Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$20.00$0.00$0.00
Net Profit-$33.76-$19.86-$56.62-$40.24
Net Profit MarginN/A-99.30%N/AN/A
Income ChangeN/A41.17%-185.10%28.93%

Rapport Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$78.31-$111.48
Net Profit MarginN/AN/A
Income ChangeN/A-42.36%

Rapport Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets13.875.13
Current Assets498.56309.8
Total Assets512.43314.93
Non Current Liabilities8.730.74
Current Liabilities19.058.77
Total Liabilities27.789.51
Shareholders' Equity484.65305.43

Rapport Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-87.47-64.83
Investing-187.47-170.14
Financing270.79221.63

About Rapport

Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its RAP technology platform includes RAP-219, an investigational small molecule being developed as a therapy for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additionally, it has two discovery-stage nicotinic acetylcholine receptor (nAChR) programs stemming from its RAP technology platform: one being developed for the treatment of chronic pain, and the second, being developed for the treatment of hearing disorders. Geographically, the company operates in the United States.

Rapport Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$25.61
$23.56
-5.78%
Oct 2026
$34.00
$25.00
-25.60%
Sep 2026
$48.88
$33.61
-33.96%
Aug 2026
$40.13
$50.89
+23.94%
Jul 2026
$41.12
$41.06
-1.65%
Jun 2026
$37.98
$41.75
+5.72%
May 2026
$32.84
$39.49
+19.09%
Apr 2026
$31.58
$33.16
+5.40%
Mar 2026
$28.41
$31.46
+8.56%
Feb 2026
$26.99
$28.98
+8.99%
Jan 2026
$30.08
$26.59
-12.40%
Dec 2025
$28.92
$30.36
+2.48%

Rapport Share Price FAQs